Evidence map›Paper›PMID 24550761›Full record

ArticleMolecular syndromology2014

A Boy with an LCR3/4-Flanked 10q22.3q23.2 Microdeletion and Uncommon Phenotypic Features.

E Petrova, C Neuner, T Haaf, M Schmid, J Wirbelauer, A Jurkutat, K Wermke, I Nanda, E Kunstmann

Abstract read
In one paragraph

Article in Molecular syndromology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

E PetrovaInstitute for Human Genetics, University of Wuerzburg, Wuerzburg, Germany.
C NeunerInstitute for Human Genetics, University of Wuerzburg, Wuerzburg, Germany.
T HaafInstitute for Human Genetics, University of Wuerzburg, Wuerzburg, Germany.
M SchmidInstitute for Human Genetics, University of Wuerzburg, Wuerzburg, Germany.
J WirbelauerUniversity Children's Hospital, University of Wuerzburg, Wuerzburg, Germany.
A JurkutatDepartment of Special Education, Speech and Language Pathology, University of Wuerzburg, Wuerzburg, Germany.
K WermkeDepartment of Orthodontics, Center for Pre-Speech Development and Developmental Disorders, University of Wuerzburg, Wuerzburg, Germany.
I NandaInstitute for Human Genetics, University of Wuerzburg, Wuerzburg, Germany.
E KunstmannInstitute for Human Genetics, University of Wuerzburg, Wuerzburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recurrent 10q22.3q23.2 deletion with breakpoints within low copy repeats 3 and 4 is a rare genomic disorder, reported in only 13 patients to date. The phenotype is rather uncharacteristic, which makes a clinical diagnosis difficult. A phenotypic feature described in almost all patients is a delay in speech development, albeit systematic studies are still pending. In this study, we report on a boy with an LCR3/4-flanked 10q22.3q23.2 deletion exhibiting an age-appropriate language development evaluated by a standardized test at an age of 2 years and 3 months. The boy was born with a cleft palate - a feature not present in any of the patients described before. Previously reported cases are reviewed, and the role of the BMPR1A gene is discussed. The phenotype of patients with an LCR3/4-flanked 10q22.3q23.2 deletion can be rather variable, so counseling the families regarding the prognosis of an affected child should be done with caution. Long-term studies of affected children are needed to delineate the natural history of this rare disorder.

Indexed as

BMPRA1Cleft palateLanguage developmentLCR3/4-flanked 10q22.3q23.2 deletion

Identifiers

PMID24550761
PMCPMC3919489

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.